NASDAQ:AKAN • CA00971M6018
The current stock price of AKAN is 0.9605 USD. In the past month the price decreased by -33.3%. In the past year, price decreased by -82.44%.
ChartMill assigns a technical rating of 1 / 10 to AKAN. When comparing the yearly performance of all stocks, AKAN is a bad performer in the overall market: 91.75% of all stocks are doing better.
ChartMill assigns a fundamental rating of 1 / 10 to AKAN. Both the profitability and financial health of AKAN have multiple concerns.
Over the last trailing twelve months AKAN reported a non-GAAP Earnings per Share(EPS) of -61.41. The EPS increased by 99.32% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -51.76% | ||
| ROE | -95.78% | ||
| Debt/Equity | 0.08 |
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 30.49 | 964.817B | ||
| JNJ | JOHNSON & JOHNSON | 21.19 | 590.254B | ||
| MRK | MERCK & CO. INC. | 22.52 | 301.963B | ||
| PFE | PFIZER INC | 8.94 | 155.618B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 9.91 | 121.595B | ||
| ZTS | ZOETIS INC | 18.53 | 56.906B | ||
| RPRX | ROYALTY PHARMA PLC- CL A | 8.7 | 26.172B | ||
| VTRS | VIATRIS INC | 6.32 | 18.486B | ||
| ELAN | ELANCO ANIMAL HEALTH INC | 24.1 | 12.312B | ||
| AXSM | AXSOME THERAPEUTICS INC | 227.33 | 9.313B |
View all stocks in the Pharmaceuticals Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
Akanda Corp. is a cannabis cultivation, manufacturing, and distribution company, which engages in the provision of premium quality and ethically sourced medical cannabis products to patients. The firm plans to develop tetrahydrocannabinol (THC) and cannabidiol (CBD) facilities.
AKANDA CORP
1A, 1B Learoyd Road
New Romney GB
Employees: 5
Phone: 442034889514
Akanda Corp. is a cannabis cultivation, manufacturing, and distribution company, which engages in the provision of premium quality and ethically sourced medical cannabis products to patients. The firm plans to develop tetrahydrocannabinol (THC) and cannabidiol (CBD) facilities.
The current stock price of AKAN is 0.9605 USD. The price increased by 3.41% in the last trading session.
AKAN does not pay a dividend.
AKAN has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
AKAN stock is listed on the Nasdaq exchange.
AKANDA CORP (AKAN) operates in the Health Care sector and the Pharmaceuticals industry.
AKANDA CORP (AKAN) currently has 5 employees.